Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-01

Clinical Trial Update: Comparing Haloperidol and Olanzapine in Treating Terminal Delirium [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing haloperidol and olanzapine for treating terminal delirium is ongoing with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • olanzapine (olanzapine)

Snippet

Sponsor: HCA Hospice Care | Conditions: Delirium, Terminal Illness | Phase 2 | Status: UNKNOWN